Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (431-440 of 522) with videos related to

Pageof 53
Sort By:
Journal of the National Cancer Institute|June 7, 2023
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancerAlejandro Berlin, Matthew Ramotar, Anna T Santiago, et al.
Prostate International|July 9, 2015
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer managementHideyuki Akaza, Choung Soo Kim, Peter Carroll, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Clinical Genitourinary Cancer|October 4, 2016
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCHDaniel M Moreira, Lauren E Howard, Katharine N Sourbeer, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
European Urology Oncology|January 1, 2026
Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH DatabaseRenning Zheng, Yuzhe Tang, Timothy J Daskivich, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
Pageof 53

Showing results (431-440 of 522) with videos related to

Sort By:
Pageof 53
Journal of the National Cancer Institute|June 7, 2023
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancerAlejandro Berlin, Matthew Ramotar, Anna T Santiago, et al.
Prostate International|July 9, 2015
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer managementHideyuki Akaza, Choung Soo Kim, Peter Carroll, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Clinical Genitourinary Cancer|October 4, 2016
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCHDaniel M Moreira, Lauren E Howard, Katharine N Sourbeer, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
European Urology Oncology|January 1, 2026
Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH DatabaseRenning Zheng, Yuzhe Tang, Timothy J Daskivich, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
Pageof 53